$Novavax (NVAX.US)$ absolutely agree 
$280 then $420 coming 
load up boys and girls !

$Novavax (NVAX.US)$  The world still has a very long way to go !!!!

Which vaccine stock do you believe has the highest upside potential?
examples include pfizer $Pfizer (PFE.US)$ , moderna $Moderna (MRNA.US)$ , novavax $Novavax (NVAX.US)$

$Novavax (NVAX.US)$ In addition to nvax’s application for South Korea’s BLA, there is also good news. India has approved SII to export 50 million conovax vaccines to Indonesia. This means that: 1. SII is indeed capable of mass production and has produced at least 10 million doses. 2 , As long as approved by other countries, SII can also supply vaccines, including developed regions such as the United Kingdom, the European Union, and Australia. In theory, there is no obstacle to eua approval, just waiting.

$Novavax (NVAX.US)$ good surge from 135 to 170. back to 300 ? awaiting some good news

$Novavax (NVAX.US)$ News: For all people who participated in clinical trials of Novavax vaccine in the UK and Mexico, the CDC in the United States accepts Novavax jabs as complete vaccinators.

$Novavax (NVAX.US)$ Not let go of less than 300

$Novavax (NVAX.US)$ From the perspective of long-term investment in stocks, this stock only needs to pass the WHO. It has long-term (1-2 years) holding value. Now we analyze the price-earnings ratio. Currently bntx is 11 times and mrna is 13 times. Nvax is expected to produce 2 billion doses next year. The current conservative order has 1.7 billion doses, and the front media reported that it will be 20 US dollars. We conservatively estimate that $10 is good, and there will be 17 billion in revenue. After deducting costs and management and consumption expenses, a surplus of 6.8 billion is calculated based on a 40% profit. After deducting the loss of about US$20 per share (74.48 million shares) in these years, the loss is about 1.6 billion. After deducting 1.6 billion, there will be a surplus of 5.2 billion. If calculated at 5 billion, the earnings per share is about 60 US dollars. The current price-to-earnings ratio of 160 is only 2.6 times. So in addition to technical lines, you should also think about its investment value.

$Novavax (NVAX.US)$ To the moon https://seekingalpha.com/article/4466338-novavax-cranks-it-up-a-billion-more-doses-covid-authorization-and-much-more